Search Results - "Iso, Yasuyoshi"
-
1
Pharmacological evaluation of novel (6-aminopyridin-3-yl)(4-(pyridin-2-yl)piperazin-1-yl) methanone derivatives as TRPV4 antagonists for the treatment of pain
Published in Bioorganic & medicinal chemistry (01-04-2017)“…[Display omitted] A novel series of (6-aminopyridin-3-yl)(4-(pyridin-2-yl)piperazin-1-yl) methanone derivatives were identified as selective transient receptor…”
Get full text
Journal Article -
2
Synthesis and structure–activity relationships of a new class of 1-oxacephem-based human chymase inhibitors
Published in Bioorganic & medicinal chemistry letters (06-11-2000)“…1-Oxacephem derivatives were synthesized and evaluated as a novel series of chymase inhibitors. Structure–activity relationship studies of 1-oxacephems led to…”
Get full text
Journal Article -
3
1-Oxacephem-based human chymase inhibitors: discovery of stable inhibitors in human plasma
Published in Bioorganic & medicinal chemistry letters (06-11-2000)“…1-Oxacephem derivatives were evaluated as a novel series of chymase inhibitors. The structure–activity relationship studies of 1-oxacephems led to compounds…”
Get full text
Journal Article -
4
Discovery of Potent and Centrally Active 6‑Substituted 5‑Fluoro-1,3-dihydro-oxazine β‑Secretase (BACE1) Inhibitors via Active Conformation Stabilization
Published in Journal of medicinal chemistry (12-07-2018)“…β-Secretase (BACE1) has an essential role in the production of amyloid β peptides that accumulate in patients with Alzheimer’s disease (AD). Thus, inhibition…”
Get full text
Journal Article -
5
Rational Design of Novel 1,3-Oxazine Based β‑Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P‑gp Efflux Leading to Robust Aβ Reduction in the Brain
Published in Journal of medicinal chemistry (28-06-2018)“…Accumulation of Aβ peptides is a hallmark of Alzheimer’s disease (AD) and is considered a causal factor in the pathogenesis of AD. β-Secretase (BACE1) is a key…”
Get full text
Journal Article -
6
Discovery of an Extremely Potent Thiazine-Based β‑Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose
Published in Journal of medicinal chemistry (24-10-2019)“…Genetic evidence points to deposition of amyloid-β (Aβ) as a causal factor for Alzheimer’s disease. Aβ generation is initiated when β-secretase (BACE1) cleaves…”
Get full text
Journal Article -
7
Design, synthesis, and binding mode prediction of 2-pyridone-based selective CB2 receptor agonists
Published in Bioorganic & medicinal chemistry (01-04-2013)“…Selective CB2 agonists have the potential for treating pain without central CB1-mediated adverse effects. Screening efforts identified…”
Get full text
Journal Article -
8
Structure–Activity Relationship Studies and Discovery of a Potent Transient Receptor Potential Vanilloid (TRPV1) Antagonist 4-[3-Chloro-5-[(1 S )-1,2-dihydroxyethyl]-2-pyridyl]- N -[5-(trifluoromethyl)-2-pyridyl]-3,6-dihydro-2 H -pyridine-1-carboxamide (V116517) as a Clinical Candidate for Pain Management
Published in Journal of medicinal chemistry (14-08-2014)Get full text
Journal Article -
9
Synthesis and modification of a novel 1 beta-methyl carbapenem antibiotic, S-4661
Published in Journal of antibiotics (01-05-1996)“…We describe an efficient method for introducing a sulfamoylamino group into the C-2' position of pyrrolidine using the Mitsunobu reaction. S-4661, its N-methyl…”
Get more information
Journal Article -
10
Trifluoromethyl Dihydrothiazine‐Based β‐Secretase (BACE1) Inhibitors with Robust Central β‐Amyloid Reduction and Minimal Covalent Binding Burden
Published in ChemMedChem (20-11-2019)“…The β‐site amyloid precursor protein cleaving enzyme 1 (BACE1, also known as β‐secretase) is a promising target for the treatment of Alzheimer's disease. A pKa…”
Get full text
Journal Article -
11
DNA Oligomers Having a Diazapyrenium Dication (DAP2+); Synthesis and DNA Cleavage Activities
Published in Chemical & pharmaceutical bulletin (01-10-1999)“…Aiming at the creation of functionalized antisense DNA oligomers possessing site-selective DNA cleaving activity, viologen and a related compound,…”
Get full text
Journal Article -
12
Selective CB2 agonists with anti-pruritic activity: Discovery of potent and orally available bicyclic 2-pyridones
Published in Bioorganic & medicinal chemistry (01-06-2013)“…The CB2 receptor has emerged as a potential target for the treatment of pruritus as well as pain without CB1-mediated side effects. We previously identified…”
Get full text
Journal Article -
13
Structure–Activity Relationship Studies and Discovery of a Potent Transient Receptor Potential Vanilloid (TRPV1) Antagonist 4‑[3-Chloro-5-[(1S)‑1,2-dihydroxyethyl]-2-pyridyl]‑N‑[5-(trifluoromethyl)-2-pyridyl]-3,6-dihydro‑2H‑pyridine-1-carboxamide (V116517) as a Clinical Candidate for Pain Management
Published in Journal of medicinal chemistry (14-08-2014)“…A series of novel tetrahydropyridinecarboxamide TRPV1 antagonists were prepared and evaluated in an effort to optimize properties of previously described lead…”
Get full text
Journal Article -
14
Discovery of novel 2′,4′-dimethyl-[4,5′-bithiazol]-2-yl amino derivatives as orally bioavailable TRPV4 antagonists for the treatment of pain: Part 1
Published in Bioorganic & medicinal chemistry letters (15-10-2016)“…[Display omitted] A novel series of 2′,4′-dimethyl-[4,5′-bithiazol]-2-yl amino derivatives were found by high throughput screening of the TRPV4 receptor, at…”
Get full text
Journal Article -
15
Discovery of novel 2′,4′-dimethyl-[4,5′-bithiazol]-2-yl amino derivatives as orally bioavailable TRPV4 antagonists for the treatment of pain: Part 2
Published in Bioorganic & medicinal chemistry letters (15-10-2016)“…[Display omitted] A series of 2′,4′-dimethyl-[4,5′-bithiazol]-2-yl amino derivatives have been identified as selective TRPV4 antagonists that display…”
Get full text
Journal Article -
16
Design, Synthesis, and SAR Studies of Mefloquine-Based Ligands as Potential Antituberculosis Agents
Published in ChemMedChem (12-06-2006)“…Potential new tuberculosis treatment: Mefloquine (1), an antimalarial drug with simple, yet interesting structural features has been found to be active against…”
Get full text
Journal Article -
17
Synthesis and Structure−Activity Relationships of 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine Analogues as Potent, Noncompetitive Metabotropic Glutamate Receptor Subtype 5 Antagonists; Search for Cocaine Medications
Published in Journal of medicinal chemistry (09-02-2006)“…Recent genetic and pharmacological studies have suggested that the metabotropic glutamate receptor subtype 5 (mGluR5) may represent a druggable target in…”
Get full text
Journal Article -
18
Efficient Synthesis of Resin-Bound α-TMSdiazoketones and Their Use in Solid-Phase Organic Synthesis
Published in Tetrahedron (21-07-2000)Get full text
Journal Article -
19
Design, Synthesis, and SAR Studies of Mefloquine-Based Ligands as Potential Antituberculosis Agents
Published in ChemMedChem (10-07-2006)Get full text
Journal Article -
20
A novel 1 beta-methylcarbapenem antibiotic, S-4661. Synthesis and structure-activity relationships of 2-(5-substituted pyrrolidin-3-ylthio)-1 beta-methylcarbapenems
Published in Journal of antibiotics (01-02-1996)“…The synthesis and biological activity of (1R,5S,6S)-2-[(3S,5S)-5-substituted pyrrolidin-3-ylthio]-6-[(1R)-1-hydroxyethyl]-1- methylcarbapen-2-em-3-carboxylic…”
Get more information
Journal Article